Blog

Targeting Tumors Smarter: How Organoids Accelerated the Rise of Petosemtamab (MCLA-158)

Targeting Tumors Smarter: How Organoids Accelerated the Rise of Petosemtamab (MCLA-158) Read More »

As the FDA begins phasing out animal testing requirements for monoclonal antibody development, new human-relevant technologies are taking the spotlight. This post explores the cutting-edge tools reshaping early drug discovery—and what this shift could mean for the future of therapeutics.